{
    "clinical_study": {
        "@rank": "156541", 
        "arm_group": [
            {
                "arm_group_label": "P1000/Ca0", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "P1000/Ca500", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "P1000/Ca1000", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The study was conducted to investigate the effect of soluble phosphate  in combination with\n      different calcium doses on calcium and phosphorus metabolism and further physiological\n      parameters in healthy subjects. The main aim of the study is to investigate the influence of\n      a soluble phosphate supplementation on the fasting blood phosphate concentration and the\n      dependency of an additional calcium intake."
        }, 
        "brief_title": "Effects of Soluble Phosphate in Humans", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Healthy Volunteers", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age between 18-60 years\n\n          -  physical health\n\n        Exclusion Criteria:\n\n          -  postmenopausal women\n\n          -  kidney diseases\n\n          -  diabetes mellitus\n\n          -  metabolic diseases\n\n          -  osteoporosis\n\n          -  intake of dietary supplements\n\n          -  pregnancy and lactation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "66", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 17, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02095392", 
            "org_study_id": "H55-14"
        }, 
        "intervention": [
            {
                "arm_group_label": "P1000/Ca0", 
                "description": "22 subjects consume for 8 weeks a beverage enriched with phosphate  [1g phosphorus/d]", 
                "intervention_name": "P1000/Ca0", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "P1000/Ca500", 
                "description": "22 subjects consume for 8 weeks a beverage enriched with phosphate [1 g phosphorus/d] and calcium [0,5 g calcium]", 
                "intervention_name": "P1000/Ca500", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "P1000/Ca1000", 
                "description": "22 subjects consume for 8 weeks a beverage enriched with phosphate [1 g phosphorus/d] and calcium [1 g calcium]", 
                "intervention_name": "P1000/Ca1000", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": [
                    "P1000/Ca0", 
                    "P1000/Ca500", 
                    "P1000/Ca1000"
                ], 
                "description": "all participants consume two weeks before intervention the beverage without phosphate and calcium", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "soluble phosphate", 
            "phosphorus metabolism", 
            "calcium metabolism", 
            "bone metabolism", 
            "human study"
        ], 
        "lastchanged_date": "April 22, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Jena", 
                    "country": "Germany", 
                    "state": "Thuringia", 
                    "zip": "07743"
                }, 
                "name": "Friedrich-Schiller-University Jena, Institute of Nutrition, Department of Nutritional Toxicology"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "4", 
        "official_title": "The Effect of Soluble Phosphate in Combination With Different Calcium Doses on Calcium and Phosphorus Metabolism in Healthy Adults", 
        "overall_official": {
            "affiliation": "Friedrich-Schiller-University Jena, Institute of Nutrition, Department of Nutritional Toxicology", 
            "last_name": "Michael Glei, Prof. Dr.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Fasting phosphate concentration in blood", 
            "safety_issue": "Yes", 
            "time_frame": "8 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02095392"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Jena", 
            "investigator_full_name": "Prof. Dr. Michael Glei", 
            "investigator_title": "Prof. Dr.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "parameters of phosphate and calcium metabolism (1,25-OHD; 25-OHD;FGF23;PTH)\nparameters of bone formation and resorption (osteocalcin, P1NP, CTX)\nminerals in plasma, faeces and urine", 
            "measure": "Calcium and phosphorus metabolism", 
            "safety_issue": "Yes", 
            "time_frame": "8 weeks"
        }, 
        "source": "University of Jena", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Jena", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}